ReN-005

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameReN-005

Drug Alias Nameneural stem cell therapy (ReNeuron)conditionally immortalized neuroepithelial stem cells (ReNeuron)CINES (ReNeuron)CINES

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Neural stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Neurogenic potential stem cell therapy

Mechanisms of ActionNeuroprotectants

TargetsUpdating

Therapy Area/IndicationsHuntington Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesReNeuron Group PLC

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesReNeuron Group PLC

Active IndicationsN/A

Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A